ARCHIVES

Bristol-Myers Squibb Board Removes CEO Peter Dolan Over Plavix Deal. Two Republican Senators Say They Will Place Holds On Confirmation of Andrew von Eschenbach as FDA Commissioner. Craig Thompson Named Director of Abramson Cancer Center.

This article is from The Cancer Letter archive.

Vol. 32 No. 32 | September 15, 2006

Download PDF Visit The Full Archive

Related Articles

Commission Urges Bypass Funding for Breast Cancer

November 5, 1993

Partnership Points to New Path Forward For Drug Approval and Clinical Research

June 20, 2014

Congressional Committees Add Provisions To Cancer Act Renewal Bills To Strengthen NCI’s Independence, Prevent Fund Withholding

March 8, 1974

ASCO, AACR Call NCI Bypass Budget A Key Advocacy Tool, Seek Larger Role In Writing It.

July 14, 2000

ASCO Guidelines On CSFs Call For Use In Fewer Patients

December 2, 1994

In Brief: Abeloff, Fisher Lead ASCO; Henney Replaces Antman On Govt. Relations; Ultmann Retires

May 31, 1991